Business ALK Abelló (ALK B) Valuation: 2025 & Allergy R&D Outlook by Sophia Patel — Business & Finance Editor 28/02/2026 by Sophia Patel — Business & Finance Editor 28/02/2026 Beyond Allergy Relief: How ALK-Abelló’s R&D Shift Signals a New Era in Precision Immunotherapy Over 30% of the global population suffers from …
